Tommaso Rossi, Director of the Ophthalmology UOC of the Bietti Foundation: «In this first year of agreement with the SSR of Lazio, the G.B. Bietti Foundation has especially increased its ability to meet the needs of citizens, through intense care activity, an expression of a project born in 1984, and is preparing to celebrate its 40th anniversary on March 1, 2024, organizing an event in Rome of masterful readings on the themes of research and assistance, with the participation of speakers and illustrious guests». Over 72,400 outpatient ophthalmological services and advanced instrumental diagnostic services; more than 3,800 surgical procedures, including hundreds of high complexity procedures like 400 retina surgery services and 350 between glaucoma draining implants and lamellar and full-thickness corneal transplants, 1,700 intravitreal injections for the treatment of maculopathies and over 1340 cataract surgery procedures. This is the positive balance of the activity of the G.B. Bietti Foundation in Rome in the first year of agreement with the Lazio Region. Important numbers, also reached with the long-term support of the Roma Foundation. In addition, the care services of the IRCCS Bietti are added to the “prolific scientific research activity that led, as the scientific director, Dr. Monica Varano, points out, in 2023, to 124 international publications, participation in about 50 international clinical trials, as well as the winning of some important competitive funding projects, the presentation of four projects for the second PNRR Health 2023 call, the organization of ECM training courses and the participation of the Foundation's researchers as speakers at important international conferences, such as ARVO in the USA and Euretina in Amsterdam».
«At our clinics, facilitated access continues for patients suffering from rare diseases, emphasizes the health director, Dr. Angela Mastromatteo: to simplify and make the patient's experience less strenuous, we have introduced a dedicated outpatient path that allows users to undergo all necessary examinations and receive the overall diagnostic-therapeutic report in a single access. In this way, we have avoided repeated accesses, guaranteeing an appropriate, complete path and a congruent use of resources, favoring integration among operators and thus reducing clinical variability and fragmentation of interventions and the risk of delays, and obtaining a high user satisfaction. To date, we have successfully managed the annual average of about 2,000 patients affected by neuro-ophthalmological diseases, genetic and rare diseases, through this approach».
This article is automatically translated